What is the Epigral Ltd share price today?

The share price of NSE:EPIGRAL-EQ on 01 Oct 2026 (as of 15:03:29 IST) is ₹978.5.

What is the NSE:EPIGRAL-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:EPIGRAL-EQ 52 week high low range shows a high of ₹1771 and a low of ₹807.

What is the Epigral Ltd market cap?

As on 01 Oct 2026, Epigral Ltd market cap is ₹43762600000.

What is the shareholding pattern of Epigral Ltd Stock?

The shareholding pattern of Epigral Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 68.83% Foreign Institutional Investors (FII): 1.03% Domestic Institutional Investors (DII): 0.04% Mutual Funds: 5.52% Retail & Others: 24.58% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Epigral Ltd?

The Price-to-Earnings (PE) ratio of Epigral Ltd is 16.1474, and the Price-to-Book (PB) ratio is 1.5721, as on 01 Oct 2026.

Epigral Share Price

912.80+0.00 (-4.07%)

-46.23% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-4.07%

1 Week

+4.38%

1 Month

-10.27%

3 Month

-16.70%

6 Month

-31.22%

YTD

-25.19%

1 Year

-46.23%

5 Year

+11.20%

10 Year

Max

+135.80%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

904.10

873.60

871.00

807.00

High

956.25

957.80

1062.00

1264.80

1350.00

1709.00

About

Epigral Limited (Formerly known as Meghmani Finechem Limited) is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The company is also engaged in trading of Agrochemical Read more

Chemicals

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SOLARINDSNSE

PIDILITINDNSE

SRFNSE

FLUOROCHEMNSE

NAVINFLUORNSE

GODREJINDNSE

DEEPAKNTRNSE

AETHERNSE

AARTIINDNSE

FINEORGNSE

EPIGRALNSE

LTP

1W Low

1W High

Market cap (₹)

19875+1075 (5.72%)

18863

20880

1,77,542Cr

1503.7+42.1 (2.88%)

1456

1528.50

1,54,308Cr

2430.5+95 (4.07%)

2336.20

2448.80

71,461Cr

4561.5+313.3 (7.37%)

4185.20

4600

48,887Cr

8674-6 (-0.07%)

8260.50

8713

43,801Cr

965.35+60.45 (6.68%)

896

980.50

32,083Cr

1548+28.6 (1.88%)

1515

1573

20,747Cr

1541.1-75.1 (-4.65%)

1490.30

1613

19,934Cr

442.65+6.9 (1.58%)

425.05

459.80

15,937Cr

5056+7 (0.14%)

5035

5424

15,598Cr

923+48.5 (5.55%)

873.60

957.80

3,938Cr

Epigral Share Price

912.80+0.00 (-4.07%)

-46.23% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years25%

3 years5%

Last year-1%

Compounded Profit Growth

10 years-

5 years27%

3 years-2%

Last year-7%

Stock Price CAGR

10 years-

5 years2%

3 years1%

1 year-46%

Return on Equity

10 years26%

5 years27%

3 years19%

Last year16%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	25%	5%	-1%
-	27%	-2%	-7%
-	2%	1%	-46%
26%	27%	19%	16%

Peer Comparison

Symbol

SOLARINDS

PIDILITIND

SRF

FLUOROCHEM

NAVINFLUOR

GODREJIND

DEEPAKNTR

AETHER

FINEORG

AARTIIND

EPIGRAL

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
19,654	₹175629 Cr	88.19	72.11	250.42	₹1678 Cr
1,510.9	₹151253 Cr	56.35	6.03	30.24	₹2449 Cr
2,428.6	₹71142 Cr	31.17	17.18	106.98	₹1835 Cr
4,463.9	₹47482 Cr	77.21	20.09	90.49	₹577 Cr
8,530	₹43119 Cr	47.35	52.48	208.91	₹664 Cr
952.55	₹31376 Cr	26.69	8.44	50.37	₹1241 Cr
1,520.6	₹20842 Cr	19.62	29.15	96.58	₹551 Cr
1,501.1	₹20181 Cr	80.97	5.12	24.71	₹219 Cr
5,089	₹15980 Cr	33.18	49.62	176.69	₹417 Cr
439.15	₹15562 Cr	26.2	4.67	29.86	₹419 Cr
912.1	₹4104 Cr	14.4	15.09	105.8	₹332 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021
₹746 Cr	₹705 Cr	₹736 Cr	₹597 Cr	₹587 Cr	₹607 Cr	₹628 Cr	₹645 Cr	₹626 Cr	₹651 Cr	₹525 Cr	₹472 Cr	₹478 Cr	₹455 Cr	₹562 Cr	₹538 Cr	₹556 Cr	₹533 Cr	₹499 Cr	₹422 Cr	₹340 Cr	₹290 Cr	₹259 Cr
₹6 Cr	₹4 Cr	-₹57 L	₹6 Cr	₹2 Cr	₹8 Cr	₹3 Cr	₹4 Cr	₹6 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹5 Cr	-₹26 L	₹2 Cr	₹2 Cr	₹2 Cr	-₹30 L	₹2 Cr	₹17 L	-₹3 L
₹752 Cr	₹709 Cr	₹736 Cr	₹603 Cr	₹589 Cr	₹615 Cr	₹631 Cr	₹649 Cr	₹632 Cr	₹654 Cr	₹526 Cr	₹474 Cr	₹479 Cr	₹456 Cr	₹567 Cr	₹538 Cr	₹557 Cr	₹535 Cr	₹501 Cr	₹422 Cr	₹342 Cr	₹291 Cr	₹259 Cr
₹654 Cr	₹569 Cr	₹609 Cr	₹537 Cr	₹497 Cr	₹485 Cr	₹488 Cr	₹496 Cr	₹480 Cr	₹508 Cr	₹400 Cr	₹380 Cr	₹402 Cr	₹391 Cr	₹438 Cr	₹402 Cr	₹401 Cr	₹367 Cr	₹345 Cr	₹303 Cr	₹261 Cr	₹219 Cr	₹199 Cr
₹142 Cr	₹183 Cr	₹168 Cr	₹108 Cr	₹134 Cr	₹172 Cr	₹177 Cr	₹186 Cr	₹184 Cr	₹179 Cr	₹157 Cr	₹125 Cr	₹109 Cr	₹97 Cr	₹159 Cr	₹166 Cr	₹182 Cr	₹189 Cr	₹177 Cr	₹141 Cr	₹103 Cr	₹93 Cr	₹80 Cr
₹11 Cr	₹7 Cr	₹16 Cr	₹11 Cr	₹22 Cr	₹23 Cr	₹12 Cr	-₹7 L	₹27 Cr	₹14 Cr	₹14 Cr	₹20 Cr	₹21 Cr	₹18 Cr	₹19 Cr	₹21 Cr	₹14 Cr	₹11 Cr	₹12 Cr	₹10 Cr	₹10 Cr	₹12 Cr	₹4 Cr
₹87 Cr	₹133 Cr	₹111 Cr	₹55 Cr	₹70 Cr	₹107 Cr	₹131 Cr	₹154 Cr	₹124 Cr	₹131 Cr	₹113 Cr	₹74 Cr	₹56 Cr	₹48 Cr	₹110 Cr	₹114 Cr	₹142 Cr	₹156 Cr	₹144 Cr	₹109 Cr	₹71 Cr	₹59 Cr	₹55 Cr
₹64 Cr	₹99 Cr	₹82 Cr	₹39 Cr	₹52 Cr	₹160 Cr	₹87 Cr	₹104 Cr	₹81 Cr	₹86 Cr	₹77 Cr	₹49 Cr	₹38 Cr	₹32 Cr	₹77 Cr	₹77 Cr	₹92 Cr	₹108 Cr	₹99 Cr	₹70 Cr	₹47 Cr	₹37 Cr	₹33 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
—	—	—	—	—	—
₹43 Cr	₹43 Cr	₹42 Cr	₹42 Cr	₹42 Cr	₹252 Cr
₹2178 Cr	₹1861 Cr	₹1213 Cr	₹1028 Cr	₹684 Cr	₹432 Cr
₹2178 Cr	₹1861 Cr	₹1213 Cr	₹1028 Cr	₹684 Cr	₹432 Cr
₹2221 Cr	₹1905 Cr	₹1254 Cr	₹1069 Cr	₹726 Cr	₹684 Cr
₹334 Cr	₹449 Cr	₹547 Cr	₹545 Cr	₹768 Cr	₹340 Cr
₹218 Cr	₹294 Cr	₹209 Cr	₹167 Cr	₹92 Cr	₹31 Cr
₹18 Cr	₹7 Cr	₹9 L	₹1 Cr	₹3 Cr	₹3 Cr
₹4 Cr	₹3 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹2 Cr
₹573 Cr	₹752 Cr	₹761 Cr	₹715 Cr	₹865 Cr	₹376 Cr
—	—	—	—	—	—
₹260 Cr	₹186 Cr	₹184 Cr	₹110 Cr	₹88 Cr	₹73 Cr
₹323 Cr	₹257 Cr	₹373 Cr	₹446 Cr	₹354 Cr	₹240 Cr
₹114 Cr	₹50 Cr	₹221 Cr	₹92 Cr	₹80 Cr	₹75 Cr
₹14 Cr	₹3 Cr	₹2 Cr	₹25 L	₹10 Cr	₹20 L
₹710 Cr	₹496 Cr	₹780 Cr	₹648 Cr	₹532 Cr	₹389 Cr
₹3505 Cr	₹3152 Cr	₹2794 Cr	₹2432 Cr	₹2124 Cr	₹1449 Cr
₹85 Cr	₹67 Cr	₹26 Cr	₹44 Cr	₹79 Cr	₹13 Cr
₹563 Cr	₹585 Cr	₹963 Cr	₹876 Cr	₹989 Cr	₹538 Cr
—	—	—	—	—	—
₹2974 Cr	₹2967 Cr	₹2406 Cr	₹2320 Cr	₹1475 Cr	₹1424 Cr
₹857 Cr	₹729 Cr	₹639 Cr	₹516 Cr	₹407 Cr	₹321 Cr
₹2117 Cr	₹2238 Cr	₹1767 Cr	₹1804 Cr	₹1068 Cr	₹1102 Cr
₹451 Cr	₹64 Cr	₹483 Cr	₹158 Cr	₹589 Cr	₹126 Cr
₹23 Cr	₹22 Cr	₹21 Cr	₹21 Cr	₹0	₹0
₹23 Cr	₹22 Cr	₹21 Cr	₹21 Cr	₹0	₹0
₹38 Cr	₹54 Cr	₹21 Cr	₹30 Cr	₹18 Cr	₹35 Cr
₹50 Cr	₹3 L	₹1 Cr	₹0	₹2 Cr	₹4 Cr
₹2679 Cr	₹2377 Cr	₹2292 Cr	₹2013 Cr	₹1677 Cr	₹1267 Cr
—	—	—	—	—	—
₹0	₹77 Cr	₹0	₹0	₹0	₹0
₹349 Cr	₹388 Cr	₹263 Cr	₹212 Cr	₹154 Cr	₹54 Cr
₹417 Cr	₹232 Cr	₹179 Cr	₹166 Cr	₹256 Cr	₹119 Cr
₹5 Cr	₹22 Cr	₹7 Cr	₹15 Cr	₹25 Cr	₹68 L
₹8 Cr	₹38 Cr	₹41 Cr	₹19 Cr	₹4 Cr	₹3 Cr
₹49 Cr	₹18 Cr	₹12 Cr	₹8 Cr	₹8 Cr	₹5 Cr
₹827 Cr	₹775 Cr	₹502 Cr	₹419 Cr	₹447 Cr	₹181 Cr
₹116 Cr	₹280 Cr	-₹278 Cr	-₹228 Cr	-₹85 Cr	-₹207 Cr
₹3505 Cr	₹3152 Cr	₹2794 Cr	₹2432 Cr	₹2124 Cr	₹1449 Cr
₹515	₹441	₹302	₹257	₹175	₹114
₹515	₹441	₹302	₹257	₹175	₹114

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
₹341 Cr	₹541 Cr	₹291 Cr	₹522 Cr	₹383 Cr	₹161 Cr
₹232 Cr	₹177 Cr	₹196 Cr	₹170 Cr	₹130 Cr	₹103 Cr
-₹64 Cr	-₹167 Cr	-₹38 Cr	₹41 Cr	-₹169 Cr	-₹6 Cr
₹508 Cr	₹551 Cr	₹448 Cr	₹734 Cr	₹344 Cr	₹258 Cr
₹436 Cr	₹441 Cr	₹398 Cr	₹626 Cr	₹284 Cr	₹229 Cr
-₹355 Cr	-₹262 Cr	-₹401 Cr	-₹437 Cr	-₹455 Cr	-₹197 Cr
-₹94 Cr	-₹164 Cr	-₹8 Cr	-₹200 Cr	₹195 Cr	-₹32 Cr
-₹14 Cr	₹15 Cr	-₹11 Cr	-₹11 Cr	₹24 Cr	₹58 L
₹19 Cr	₹3 Cr	₹14 Cr	₹25 Cr	₹68 L	₹10 L
₹5 Cr	₹19 Cr	₹3 Cr	₹14 Cr	₹25 Cr	₹68 L

Fundamental Ratios

Consolidated

Standalone

No results found

Epigral Share Price

912.80+0.00 (-4.07%)

-46.23% past 1 Year

Shareholding summary

Promoters

68.83%

FII

0.99%

DII

0.02%

4.87%

Others

25.29%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
68.83%	68.83%	68.83%	68.83%	68.83%	68.83%
0.99%	1.03%	1.54%	2.36%	2.71%	3.06%
0.02%	0.04%	0.00%	0.04%	0.18%	0.19%
4.87%	5.52%	4.90%	5.09%	4.74%	4.59%
25.29%	24.58%	24.73%	23.68%	23.54%	23.33%

Bulk & block deals

Name

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange

Insider trading & SAST

Client name

Ashishbhai Natwarlal Soparkar

Rameshbhai Meghjibhai Patel

Maulik Jayantibhai Patel

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
20 Jun 2024	Other	Acquisition	1.59	—	0	—	6.61 L	05 Jun 2024	-	—	SAST	10(6)	—
04 Jun 2024	Other	Acquisition	2.5	—	0	—	10.39 L	28 May 2024	-	—	SAST	10(6)	—
22 May 2024	Promoter	Acquisition	4.09	—	0	—	17 L	28 May 2024	—	—	SAST	10(5)	—
05 Jun 2023	Promoter	Acquisition	0.012034	7.05	48.38 L	₹967.57	5 K	05 Jun 2023	Market Purchase	29,29,569	Insider Trading	—	Equity Shares
01 Jun 2023	Promoter	Acquisition	0.012034	7.04	46.02 L	₹920.46	5 K	30 May 2023	Market Purchase	29,24,569	Insider Trading	—	Equity Shares
20 Mar 2023	Promoter	Acquisition	0.001925	5.18	7.19 L	₹898.81	800	17 Mar 2023	Market Purchase	21,54,367	Insider Trading	—	Equity Shares
17 Mar 2023	Promoter	Acquisition	0.004813	5.18	17.78 L	₹889.19	2 K	16 Mar 2023	Market Purchase	21,53,567	Insider Trading	—	Equity Shares
16 Mar 2023	Promoter	Acquisition	0.01083	5.18	42.85 L	₹952.18	4.50 K	15 Mar 2023	Market Purchase	21,51,567	Insider Trading	—	Equity Shares
15 Mar 2023	Promoter	Acquisition	0.012034	5.17	48.38 L	₹967.67	5 K	14 Mar 2023	Market Purchase	21,47,067	Insider Trading	—	Equity Shares
07 Mar 2023	Promoter	Acquisition	0.003085	5.16	13.14 L	₹1,024.65	1.28 K	24 Feb 2023	Market Purchase	21,42,067	Insider Trading	—	Equity Shares

Epigral Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Epigral Share Price

Epigral Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Epigral Share Price

Epigral Share Price

Oscillators

Moving averages

Epigral Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Epigral Share Price

Corporate Actions

Company details

Epigral Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Epigral Share Price

News

Epigral Managing Director Maintains Optimistic Outlook For Second Half Of FY27

Epigral Reports Strong Year On Year Growth In Second Quarter Revenue

Epigral Reports Higher Q2 EBITDA Despite Year On Year Margin Compression

Epigral Reports Strong Year On Year Growth In Second Quarter Net Profit

Epigral Targets Rs 5,000 Crore Revenue By FY31 Through Capacity Expansion

Epigral schedules analyst and investor interaction via plant visit on September 3

Epigral to host analyst and investor meeting on August 20, 2026

Epigral board approves strategic capex for epoxy resin and new multi-purpose plant

Epigral plans multi-purpose plant capex, targets Rs 500 crore revenue

Epigral announces Rs 600 crore Dahej epoxy resin capacity expansion plan

Epigral posts strong Q1 revenue growth of 16.7 percent year-on-year

Epigral Q1 EBITDA grows year-on-year, margin contracts versus prior period

Epigral Q1 consolidated net profit declines sharply on yearly basis

Epigral forms Epigral Advanced Materials unit to expand advanced chemical manufacturing

Epigral cut to Reduce as Incred flags Chinese oversupply risk

Epigral informs about newspaper publication

Epigral - Quaterly Results

Epigral Reports 15% QoQ Sales Volume Growth with Plant Utilization Over 80%

Epigral reports Profit after tax of 81.93 Crores, in the March 2026 quarter

Epigral Board Recommends Final Dividend of Rs 5 Per Equity Share

Epigral Ltd Share Price Today

Epigral Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator